Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Arango, C.
Buchanan, R.W.
Kirkpatrick, B.
and
Carpenter, W.T.
2004.
El síndrome deficitario en la esquizofrenia: implicaciones para el tratamiento de los síntomas negativos.
European psychiatry (Ed. Española),
Vol. 11,
Issue. 4,
p.
219.
Thorup, A.
Petersen, L.
Jeppesen, P.
Øhlenschlæger, J.
Christensen, T.
Krarup, G.
Jørgensen, P.
and
Nordentoft, M.
2005.
Integrated treatment ameliorates negative symptoms in first episode psychosis—results from the Danish OPUS trial.
Schizophrenia Research,
Vol. 79,
Issue. 1,
p.
95.
Carpenter, William T.
2006.
The Schizophrenia Paradigm.
Journal of Nervous & Mental Disease,
Vol. 194,
Issue. 9,
p.
639.
Pae, Chi‐Un
2006.
Comments on MCP‐1 gene (SCYA2) and schizophrenia: A case‐control association study.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
Vol. 141B,
Issue. 2,
p.
193.
Yoon, Jong H.
D'Esposito, Mark
and
Carter, Cameron S.
2006.
Preserved function of the fusiform face area in schizophrenia as revealed by fMRI.
Psychiatry Research: Neuroimaging,
Vol. 148,
Issue. 2-3,
p.
205.
Ghose, Subroto
and
Tamminga, Carol
2007.
Handbook of Contemporary Neuropharmacology.
Montoya, Ivan D.
and
Vocci, Frank
2007.
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.
Journal of Dual Diagnosis,
Vol. 3,
Issue. 3-4,
p.
113.
Rao, Vani
Spiro, Jennifer R.
Schretlen, David J.
and
Cascella, Nicola G.
2007.
Apathy Syndrome After Traumatic Brain Injury Compared With Deficits in Schizophrenia.
Psychosomatics,
Vol. 48,
Issue. 3,
p.
217.
Kohler, Christian G.
Martin, Elizabeth A.
Kujawski, Evan
Bilker, Warren
Gur, Raquel E.
and
Gur, Ruben C.
2007.
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
Cognitive Neuropsychiatry,
Vol. 12,
Issue. 5,
p.
412.
Arango, C.
Gómez-Beneyto, M.
Brenlla, J.
Gastó, C.
Sarramea-Crespo, F.
Chamorro, L.
Masramon, X.
and
Díez, T.
2007.
A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia.
European Neuropsychopharmacology,
Vol. 17,
Issue. 6-7,
p.
456.
Velligan, Dawn I.
Diamond, Pamela
Glahn, David C.
Ritch, Janice
Maples, Natalie
Castillo, Desiree
and
Miller, Alexander L.
2007.
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).
Psychiatry Research,
Vol. 151,
Issue. 1-2,
p.
55.
Češková, Eva
Radovan, Přikryl
Tomáš, Kašpárek
and
Hana, Kučerová
2007.
One-year follow-up of patients with fi rst-episode schizophrenia (comparison between remitters and non-remitters).
Neuropsychiatric Disease and Treatment,
Vol. 3,
Issue. 1,
p.
153.
Wang, Xiang
Yao, Shuqiao
Kirkpatrick, Brian
Shi, Chuan
and
Yi, Jinyao
2008.
Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.
Psychiatry Research,
Vol. 158,
Issue. 2,
p.
195.
Siegel, Steven J.
Dankert, Mary E.
and
Phillips, Jennifer M.
2009.
Pharmacology and Therapeutics.
p.
797.
Fischer, B. A.
Kirkpatrick, B.
and
Carpenter, W. T.
2009.
Handbook of Neurochemistry and Molecular Neurobiology.
p.
505.
Velligan, Dawn I.
Alphs, Larry
Lancaster, Scott
Morlock, Robert
and
Mintz, Jim
2009.
Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
Psychiatry Research,
Vol. 169,
Issue. 2,
p.
97.
Kinon, Bruce J.
Chen, Lei
Ascher-Svanum, Haya
Stauffer, Virginia L.
Kollack-Walker, Sara
Zhou, Wei
Kapur, Shitij
Kane, John M.
and
Naber, Dieter
2010.
Challenging the assumption that improvement in functional outcomes is delayed relative to improvement in symptoms in the treatment of schizophrenia.
Schizophrenia Research,
Vol. 118,
Issue. 1-3,
p.
176.
Cohen, Alex S.
Brown, Laura A.
and
Minor, Kyle S.
2010.
The psychiatric symptomatology of deficit schizophrenia: A meta-analysis.
Schizophrenia Research,
Vol. 118,
Issue. 1-3,
p.
122.
Perez‐Costas, Emma
Melendez‐Ferro, Miguel
and
Roberts, Rosalinda C.
2010.
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
Journal of Neurochemistry,
Vol. 113,
Issue. 2,
p.
287.
Coyle, Joseph T.
Balu, Darrick
Benneyworth, Michael
Basu, Alo
and
Roseman, Alexander
2010.
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.
Dialogues in Clinical Neuroscience,
Vol. 12,
Issue. 3,
p.
359.
Comments
No Comments have been published for this article.